We studied the antitumor activity of the combined use of local proton irradiation in two modes (10 and 31 Gy) with preliminary intra-tumoral injection of two types of bismuth nanoparticles differing in surface coating: coated with the amphiphilic molecule Pluronic-F127 or Silane-PEG (5 kDa)-COOH polymer. Nanoparticles were used in doses of 0.75 and 1.5 mg/mouse. In two independent series on experimental tumor model (solid Ehrlich carcinoma), bismuth nanoparticles of both modifications injected directly into the tumor enhanced the antitumor effects of proton therapy. Moreover, the radiosensitizing effect of bismuth nanoparticles administered via this route increased with the increasing the doses of nanoparticles and the doses of radiation exposure. In our opinion, these promising data obtained for the first time extend the possibilities of treating malignant neoplasms.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Boateng F, Ngwa W. Delivery of nanoparticle-based radiosensitizers for radiotherapy applications. Int. J. Mol. Sci. 2019;21(1):273. https://doi.org/10.3390/ijms21010273
Gong L, Zhang Y, Liu C, Zhang M, Han S. Application of radiosensitizers in cancer radiotherapy. Int. J. Nanomedicine. 2021;16:1083-1102. https://doi.org/10.2147/IJN.S290438
Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. Gold nanoparticles: a new X-ray contrast agent. Br. J. Radiol. 2006;79(939):248-253. https://doi.org/10.1259/bjr/13169882
Li J, Chaudhary A, Chmura SJ, Pelizzari C, Rajh T, Wietholt C, Kurtoglu M, Aydogan B. A novel functional CT contrast agent for molecular imaging of cancer. Phys. Med. Biol. 2010;55(15):4389-4397. https://doi.org/10.1088/0031-9155/55/15/013
Meidanchi A, Akhavan O, Khoei S, Shokri AA, Hajikarimi Z, Khansari N. ZnFe2O4 nanoparticles as radiosensitizers in radiotherapy of human prostate cancer cells. Mater. Sci. Eng. C Mater. Biol. Appl. 2015;46:394-399. https://doi.org/10.1016/j.msec.2014.10.062
Shameer Ahmed B, Rao AG, Sankarshan BM, Vicas CS, Namratha K, Umesh TK, Somashekar R, Byrappa K. Evaluation of gold, silver and silver–gold (bimetallic) nanoparticles as radiosensitizers for radiation therapy in cancer treatment. Cancer Oncol. Res. 2016;4(3):42-51. https://doi.org/10.13189/cor.2016.040302
Wang H, Mu X, He H, Zhang XD. Cancer radiosensitizers. Trends Pharmacol. Sci. 2018;39(1):24-48. https://doi.org/10.1016/j.tips.2017.11.003
Roy I, Krishnan S, Kabashin AV, Zavestovskaya IN, Prasad PN. Transforming nuclear medicine with nanoradiopharmaceuticals. ACS Nano. 2022;16(4):5036-5061. https://doi.org/10.1021/acsnano.1c10550
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 176, No. 11, pp. 647-652, November, 2023
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Filimonova, M.V., Soldatova, O.V., Shitova, A.A. et al. Bismuth Nanoparticles Increase Effectiveness of Proton Therapy of Ehrlich Carcinoma. Bull Exp Biol Med 176, 626–630 (2024). https://doi.org/10.1007/s10517-024-06081-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-024-06081-4